VCU spinout BioCircuit Technologies raises $9M to bring Nerve Tape to market


The company received Section 510(k) clearance from the Food and Drug Administration for its product.

Previous Colorado biotech company to go public via SPAC merger
Next Four Oregon wines make Wine Spectator's Top 100 for 2022